Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (63)
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
1976 • 2,468 citations
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
2002 • 2,268 citations
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 • 2,026 citations
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 • 1,828 citations
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide
2003 • 1,597 citations
Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex
2003 • 1,361 citations
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
1997 • 1,290 citations
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
1995 • 1,207 citations
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
2001 • 1,032 citations
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
1997 • 886 citations
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
1997 • 777 citations
Characterization of EBV‐genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non‐Hodgkin lymphoma
1977 • 698 citations
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
2003 • 630 citations
Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating Activity
1978 • 537 citations
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
1983 • 517 citations
Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
1994 • 510 citations
Targeting tumours with genetically enhanced T lymphocytes
2003 • 508 citations
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
1996 • 439 citations
Haematopoietic cell transplantation as immunotherapy
2001 • 415 citations
Cutting Edge: 4-1BB Is a Bona Fide CD8 T Cell Survival Signal
1999 • 379 citations
Costimulation of CD28- T lymphocytes by 4-1BB ligand.
1997 • 333 citations
Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics
1985 • 331 citations
Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest
1997 • 283 citations
T-cell-receptor gene therapy
2002 • 266 citations
Childhood acute lymphoblastic leukaemia – current status and future perspectives
2001 • 266 citations
Bone marrow-derived stromal cells prevent apoptotic cell death in B- lineage acute lymphoblastic leukemia
1992 • 265 citations
Structure, Function, and Serology of the T-Cell Antigen Receptor Complex
1987 • 264 citations
Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
1997 • 256 citations
Donor leukocyte infusions in acute lymphocytic leukemia
2000 • 248 citations
T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect
2003 • 244 citations
Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway
1998 • 218 citations
Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma
1997 • 205 citations
Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line
1979 • 201 citations
Synthetic activation of caspases: Artificial death switches
1998 • 186 citations
Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen
1996 • 173 citations
Immunophenotyping of leukemia
2000 • 168 citations
Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB
2002 • 162 citations
Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen
1996 • 149 citations
Genetic Modification of Human T Cells with CD20: A Strategy to Purify and Lyse Transduced Cells with Anti-CD20 Antibodies
2000 • 143 citations
Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase
2003 • 141 citations
Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses
1998 • 131 citations
Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell–depleted stem cell transplantation
2003 • 130 citations
The Graft-Versus-Leukemia Effects of Allogeneic Cell Therapy
1999 • 130 citations
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
2002 • 124 citations
Hyperdiploid Acute Lymphoblastic Leukemia With 51 to 65 Chromosomes: A Distinct Biological Entity With a Marked Propensity to Undergo Apoptosis
1999 • 104 citations
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
1996 • 82 citations
Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia
1994 • 79 citations
Costimulation of human CD28– T cells by 4‐1BB ligand
2003 • 73 citations
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells
1998 • 71 citations
Tumour rejection by gene transfer of 4-1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells
2000 • 59 citations
Costimulatory approaches to adoptive immunotherapy
1998 • 57 citations
T-Cell Depletion to Prevent Graft-Versus-Host Disease After Bone Marrow Transplantation
1990 • 54 citations
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer
2002 • 54 citations
Prevalence and Growth Characteristics of Malignant Stem Cells in B-Lineage Acute Lymphoblastic Leukemia
1997 • 50 citations
Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs.
1993 • 45 citations
Prevalence and Growth Characteristics of Malignant Stem Cells in B-Lineage Acute Lymphoblastic Leukemia
1997 • 40 citations
Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach
2001 • 28 citations
A novel adenovirus expressing human 4–1BB ligand enhances antitumor immunity
2003 • 26 citations
Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells
2001 • 25 citations
Development and application of receptor-modified T lymphocytes for adoptive immunotherapy
2001 • 24 citations
The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis
2002 • 18 citations
‘Ponte di Legno’ Working Group – Report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April – 1 May 2002
2003 • 11 citations
Signals mediated by FcγRIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells
2002 • 10 citations